Cardio-Oncology

Increased Incidence of De Novo Malignancies Compared With Malignancy Recurrences in Survivors of Cancer Undergoing Heart Transplantation 2026 Heart Disease and Stroke Statistics Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell–Derived Cardiomyocytes, Organoids, and Mouse Models CXCR6+ T Cells Drive Immune Checkpoint Inhibitor Myocarditis What is VTE: Why Does it Matter? Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications Response by Glargaard and Thune to Letters Regarding Article, “A Randomized Trial of Thoracentesis in Acute Heart Failure” Increased Cardiovascular Risk With Lorlatinib in Patients With ALK‐Mutated Lung Cancer: A Real‐World Comparative Study Prognostic Value of Baseline and Soluble ST2 Change in Patients With Light Chain Cardiac Amyloidosis